subject: UNII:FYS6T7F842

object_name: uveal melanoma


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: mucosal melanoma

tested_intervention: unsure


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: skin melanoma


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UMLS:C5447766

object_name: melanoma


subject: UMLS:C5447766


subject: UMLS:C5447766


subject: UMLS:C5447766


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: CHEBI:8988

object_name: biliary tract neoplasm


subject: CHEBI:80630

subject_name: Irinotecan


subject: MESH:C079198

subject_name: S 1 (combination)


subject: CHEBI:3112

subject_name: Biperiden

object_name: cocaine dependence

tested_intervention: yes


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: squamous cell carcinoma


subject: GTOPDB:11376

object_name: esophageal cancer


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:72317

object_name: Embolism, Tumor


subject: CHEBI:72317

object_name: Neoplasm Metastasis


subject: CHEBI:231614

subject_name: Nivolumab

object_name: castration-resistant prostate carcinoma


subject: UMLS:C2346820


subject: CHEBI:73286

subject_name: Piclidenoson


subject: CHEBI:73286

object_name: Coronavinae infectious disease


subject: CHEBI:6970

subject_name: Mometasone

object_name: radiodermatitis


subject: UNII:82VH67YON8

subject_name: PIFLUFOLASTAT

object_name: prostate adenocarcinoma


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:3080587

object_name: uterine corpus cancer


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Hip dysplasia


subject: CHEBI:28918

object_name: Hip Dysplasia


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6129


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: UMLS:C5855548

subject_name: Copper Cu 64 FBP8

object_name: Alzheimer disease type 1


subject: UMLS:C5855548

object_name: Alzheimer disease


subject: UMLS:C2987686

subject_name: Sodium Bicarbonate Solution

object_name: contrast-induced nephropathy


subject: UMLS:C1550678

subject_name: Water Specimen

object_name: dehydration (Na, H2O)


subject: UMLS:C1550678

object_name: Dehydration, CTCAE


subject: UMLS:C1550678

object_name: Dehydration


subject: UMLS:C1550678

object_name: stroke disorder


subject: UMLS:C1550678

object_name: cerebrovascular disorder


subject: UMLS:C1550678

object_name: Stroke (heart beat)


subject: UMLS:C1550678

object_name: Stroke, CTCAE


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377


subject: CHEBI:15377


subject: CHEBI:15377


subject: CHEBI:15377


subject: CHEBI:15377


subject: CHEBI:15377


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Adolescent Obesity


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Pancreatic neuroendocrine tumour metastatic


subject: CHEBI:31348

object_name: Unresectable Pancreatic Neuroendocrine Carcinoma


subject: UNII:MRL3739G66

subject_name: Dotatate


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:18132

subject_name: phosphocholine

object_name: adult lymphoma


subject: CHEBI:18132

object_name: lymphoma


subject: CHEBI:18132

object_name: pediatric lymphoma


subject: UniProtKB:Q62857

subject_name: DDIT3_RAT DNA damage-inducible transcript 3 protein (sprot)


subject: UniProtKB:Q62857


subject: UniProtKB:Q62857


subject: PR:000006347

subject_name: DNA damage-inducible transcript 3 protein


subject: PR:000006347


subject: PR:000006347


subject: CHEBI:94295

subject_name: Darinaparsin


subject: CHEBI:94295


subject: CHEBI:94295


subject: UNII:WP6PY72ZH3

subject_name: Motolimod

object_name: ovarian cancer


subject: UNII:WP6PY72ZH3

object_name: ovarian neoplasm


subject: UNII:WP6PY72ZH3

object_name: ovarian carcinoma


subject: CHEBI:85980

subject_name: Eluxadoline

object_name: irritable bowel syndrome


subject: CHEBI:68596

subject_name: alpha-Asp-Leu

object_name: Acute Ischemic Stroke


subject: CHEBI:68596

object_name: Ischemic stroke


subject: CHEBI:68596

object_name: hyperglycemia


subject: CHEBI:68596

object_name: Hyperglycemia, CTCAE


subject: CHEBI:68596

object_name: Glucose in blood specimen above reference range


subject: CHEBI:68596

object_name: type 2 diabetes mellitus


subject: CHEBI:68596

object_name: Diabetes


subject: CHEBI:68596

object_name: diabetes mellitus


subject: CHEBI:229469

subject_name: Sulodexide

object_name: dense deposit disease


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine

object_name: adult germ cell tumor


subject: PUBCHEM.COMPOUND:136924190

object_name: germ cell tumor


subject: PUBCHEM.COMPOUND:136924190

object_name: childhood germ cell tumor


subject: PUBCHEM.COMPOUND:136924190

object_name: Germ Cell Cancer


subject: PUBCHEM.COMPOUND:136924190

object_name: testicular cancer


subject: PUBCHEM.COMPOUND:136924190

object_name: malignant testicular germ cell tumor


subject: PUBCHEM.COMPOUND:136924190

object_name: neoplasm of testis


subject: UMLS:C2986994


subject: UMLS:C2986994


subject: UMLS:C2986994


subject: UMLS:C2986994


subject: UMLS:C2986994


subject: UMLS:C2986994


subject: UMLS:C2986994


subject: CHEBI:94771

subject_name: Quisinostat

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:94771

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:90528

subject_name: Neflamapimod

object_name: Lewy Bodies


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: nasopharyngeal carcinoma


subject: UNII:9G6U5L461Q

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:50172

subject_name: acitretin

object_name: Alzheimer disease type 1


subject: CHEBI:50172

object_name: Alzheimer disease


subject: CHEBI:50174


subject: CHEBI:50174


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Small cell lung cancer limited stage


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Knee Injuries


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: stroke disorder


subject: UNII:9603LN7R2Q

object_name: cerebrovascular disorder


subject: UNII:9603LN7R2Q

object_name: Stroke (heart beat)


subject: UNII:9603LN7R2Q

object_name: Stroke, CTCAE


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:16919


subject: CHEBI:16919


subject: CHEBI:16919


subject: PUBCHEM.COMPOUND:71080313

subject_name: Volasertib

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:71080313

object_name: lymphoma


subject: PUBCHEM.COMPOUND:71080313

object_name: pediatric lymphoma


subject: UNII:6EM57086EA


subject: UNII:6EM57086EA


subject: UNII:6EM57086EA


subject: UMLS:C4744685

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4744685

object_name: acute myeloid leukemia


subject: UNII:OSL3FEZ1IF

subject_name: Lisaftoclax


subject: UNII:OSL3FEZ1IF


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: skin squamous cell carcinoma


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C5203471

subject_name: Dexmedetomidine Liquid Injection

object_name: cesarean section; complications


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UMLS:C3813201

subject_name: Oral Rehydration Solution OS-1

object_name: mortality


subject: MESH:C034130

subject_name: ORALIT


subject: UMLS:C2344255

subject_name: BD Alcohol

object_name: amyloidosis


subject: CHEBI:52683

subject_name: Butylene glycol


subject: UMLS:C4724025

subject_name: babaodan capsule


subject: UMLS:C5551437

subject_name: babao dan


subject: CHEBI:231347

subject_name: Triapine

object_name: Ovarian cancer stage III


subject: CHEBI:231347

object_name: peritoneum cancer


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: gastric ulcer


subject: CHEBI:6375

object_name: Gastric Ulcer, CTCAE


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Diabetic peripheral neuropathy


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: tumor suppressor gene on chromosome 11


subject: CHEBI:63791

object_name: lung cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: bacterial pneumonia


subject: CHEBI:51254

object_name: ventilator-associated pneumonia


subject: CHEBI:51254

object_name: Community-Acquired Infections


subject: CHEBI:51254

object_name: Cross Infection


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:478164

subject_name: Cefepime


subject: CHEBI:478164


subject: CHEBI:478164


subject: CHEBI:478164


subject: CHEBI:135928

subject_name: Doripenem


subject: CHEBI:135928


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: disseminated eosinophilic collagen disease


subject: UNII:71492GE1FX

object_name: idiopathic hypereosinophilic syndrome


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Antibody-mediated rejection


subject: CHEBI:52717

object_name: late rejection of renal transplant


subject: CHEBI:141441

subject_name: Ile-Thr

object_name: lymphoblastic lymphoma


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: hereditary hemorrhagic telangiectasia


subject: CHEBI:85164


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Periodontal Pocket


subject: UNII:M09888Y92S

subject_name: SILK FIBROIN


subject: UMLS:C0016042

subject_name: Fibroins


subject: CHEBI:9352

subject_name: Sulindac

object_name: classic familial adenomatous polyposis


subject: CHEBI:9352

object_name: Adenomatous colonic polyposis


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:2269

object_name: abortion in first trimester


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:2Y3T5IF01Z

object_name: Adult Soft Tissue Sarcoma


subject: UNII:2Y3T5IF01Z

object_name: sarcoma


subject: UNII:2Y3T5IF01Z

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:2Y3T5IF01Z

object_name: soft tissue sarcoma


subject: UNII:2Y3T5IF01Z

object_name: malignant soft tissue neoplasm


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: mild neurocognitive disorder


subject: CHEBI:135285

object_name: mild cognitive impairment


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:3062

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:3062

object_name: breast cancer


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:4551


subject: UMLS:C1744162

subject_name: RPL 554

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:7563

subject_name: N-nicotinoylglycine

object_name: arteriosclerosis disorder


subject: CHEBI:7563

object_name: atherosclerosis


subject: MESH:D009539

subject_name: Nicotinic Acids


subject: MESH:D009539


subject: UMLS:C3714626

subject_name: Nicotinic Acid Drug Class


subject: UMLS:C3714626


subject: UMLS:C3536880

subject_name: Nicotinic Acid [EPC]


subject: UMLS:C3536880


subject: UMLS:C2347401

subject_name: Oral Microencapsulated Diindolylmethane

object_name: cervical cancer


subject: UMLS:C2347401

object_name: cervical carcinoma


subject: UMLS:C2347401

object_name: precancerous condition


subject: CHEBI:27470

subject_name: Folic acid

object_name: contact exposure to arsenic (history)


subject: CHEBI:27470

object_name: Arsenic Exposure


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: PUBCHEM.COMPOUND:25127414


subject: UNII:0ICW2LX8AS

subject_name: Bemcentinib


subject: UNII:889I657R9P

subject_name: Desmethylsibutramine

object_name: obstructive sleep apnea syndrome


subject: UNII:987R943R3P

subject_name: Didesmethylsibutramine


subject: CHEBI:9137

subject_name: Sibutramine


subject: UNII:5M691HL4BO

subject_name: glatiramer acetate

object_name: macular degeneration


subject: UNII:5M691HL4BO

object_name: age-related macular degeneration


subject: UNII:5M691HL4BO

object_name: retinitis pigmentosa 30


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Stage III Skin Cancer


subject: UNII:B72HH48FLU

object_name: Drug-induced colitis


subject: UNII:B72HH48FLU

object_name: Stage IV Skin Cancer


subject: UNII:B72HH48FLU

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UNII:B72HH48FLU

object_name: immune-mediated adverse reaction


subject: UNII:B72HH48FLU

object_name: Drug toxicity


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888

object_name: metastatic melanoma


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:28253

object_name: type 2 diabetes mellitus


subject: CHEBI:28253

object_name: periodontal disorder


subject: CHEBI:28253

object_name: periodontitis


subject: CHEBI:28253

object_name: Periodontal Disease, CTCAE


subject: CHEBI:15407

subject_name: Ephedrine

object_name: Birthing Labor


subject: GTOPDB:12989

subject_name: toripalimab

object_name: trachea squamous cell carcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C3275195

subject_name: Celsentri

object_name: HIV-1 infection


subject: UMLS:C3275195

object_name: AIDS


subject: UNII:9Z74BD3QPP

subject_name: LIDORESTAT

object_name: diabetic polyneuropathy


subject: UNII:R3734K0M7L

subject_name: Lidorestat


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Ankle Injuries and Disorders


subject: CHEBI:41879

object_name: Foot Injuries and Disorders


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: CHEBI:4466


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:3T25U84H4U

subject_name: TELOTRISTAT ETIPRATE

object_name: carcinoid syndrome


subject: PUBCHEM.COMPOUND:72959169

subject_name: Mayzent

object_name: multiple sclerosis


subject: UNII:RR6P8L282I

subject_name: Siponimod


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: retinitis pigmentosa


subject: CHEBI:36005

object_name: retinitis pigmentosa 1


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: MESH:C000708357

subject_name: weifuchun

object_name: chronic atrophic gastritis with hyperplasia


subject: UMLS:C5392569


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Acute upper respiratory infection


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UMLS:C5856615

subject_name: Jianpi Qushi Huatan Decoction

object_name: Androgen excess


subject: UNII:T5W3M0VO9B

object_name: psoriasis


subject: UMLS:C0742246

subject_name: CHEMOTHERAPY CIS PLATIN

object_name: bladder tumor


subject: UMLS:C0742246

object_name: urinary bladder carcinoma


subject: UMLS:C0742246

object_name: urinary bladder cancer


subject: UMLS:C0742246

object_name: childhood bladder carcinoma


subject: CHEBI:51141

subject_name: Alfuzosin

object_name: hydronephrosis


subject: CHEBI:51141

object_name: cauda equina syndrome with neurogenic bladder


subject: CHEBI:51141

object_name: Neurogenic bladder


subject: CHEBI:4653

subject_name: Dipyridamole

object_name: pterygium


subject: CHEBI:4653

object_name: conjunctival pterygium


subject: CHEBI:4653

object_name: dry eye syndrome


subject: UNII:950O97NUPO

subject_name: Preladenant

object_name: brain disorder


subject: UNII:950O97NUPO

object_name: neurodegenerative disease


subject: UNII:950O97NUPO

object_name: CNS disorder


subject: GTOPDB:8966

subject_name: onartuzumab

object_name: Childhood Breast Carcinoma


subject: GTOPDB:8966

object_name: breast carcinoma


subject: GTOPDB:8966

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL1743051

subject_name: ONARTUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743051


subject: CHEMBL.COMPOUND:CHEMBL1743051


subject: UMLS:C2826110


subject: UMLS:C2826110


subject: UMLS:C2826110


subject: CHEBI:6432

subject_name: Levamisole

object_name: Status epilepticus


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:144459

subject_name: Lys-Glu-Thr


subject: PR:000016567

subject_name: tumor protein 63


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Generalized severe chronic periodontitis


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: UMLS:C5783010

object_name: Childhood Solid Neoplasm


subject: UMLS:C5783010

object_name: Adult Solid Neoplasm


subject: UMLS:C5783010

object_name: Solid Neoplasm


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: endometrial cancer


subject: CHEBI:82677

object_name: uterine corpus cancer


subject: CHEBI:82677

object_name: endometrial carcinoma


subject: UMLS:C3896920

subject_name: MDM2/MDMX Inhibitor ALRN-6924

object_name: adult lymphoma


subject: UMLS:C3896920

object_name: lymphoma


subject: UMLS:C3896920

object_name: pediatric lymphoma


subject: UMLS:C3896920

object_name: brain neoplasm


subject: UMLS:C3896920

object_name: leukemia


subject: UMLS:C3896920

object_name: childhood leukemia


subject: UMLS:C3896920


subject: UMLS:C3896920


subject: UMLS:C3896920


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: UNII:3VHF2ZD92J

subject_name: Romosozumab

object_name: spinal cord injury


subject: UNII:3VHF2ZD92J

object_name: Osteoporotic Fractures


subject: CHEBI:138865

subject_name: Mavorixafor

object_name: liver failure


subject: CHEBI:59004

subject_name: Hypericum

object_name: mood disorder


subject: UMLS:C1706292

subject_name: Hypericum extract


subject: UMLS:C0966327


subject: CHEBI:8863

subject_name: Riluzole

object_name: Depressed mood


subject: CHEBI:8863

object_name: Cancer patients and suicide and depression


subject: CHEBI:8863

object_name: Depressed - symptom


subject: CHEBI:8863

object_name: Depression, CTCAE


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Arthralgia


subject: CHEBI:93775

object_name: Arthralgia, CTCAE


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:39585

subject_name: Carbidopa

object_name: insomnia


subject: CHEBI:39585

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:39585

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:39585

object_name: Transient Insomnia


subject: CHEBI:39585

object_name: Insomnia due to anxiety and fear


subject: CHEBI:39585

object_name: insomnia type; sleep disorder


subject: CHEBI:39585

object_name: Insomnia due to other mental disorder


subject: CHEBI:39585

object_name: Dyssomnias


subject: CHEBI:39585

object_name: Sleep abnormality


subject: CHEBI:39585

object_name: sleep disorder


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: PUBCHEM.COMPOUND:521372


subject: UNII:WTT295HSY5

subject_name: Dulaglutide

object_name: Metabolic stress hyperglycemia


subject: UMLS:C2976495


subject: GTOPDB:11607

subject_name: barzolvolimab

object_name: chronic idiopathic urticaria


subject: UNII:4B77GX0NA3

subject_name: BARZOLVOLIMAB


subject: UMLS:C5669595

subject_name: Barzolvolimab


subject: CHEBI:6741

subject_name: Meloxicam

object_name: Post-Operative Pain


subject: UNII:1H7RSQ28BJ

subject_name: Ibodutant

object_name: Irritable bowel syndrome with diarrhea


subject: UMLS:C3180273

subject_name: ibodutant


subject: CHEBI:5613

subject_name: Haloperidol

object_name: Cognitive impairment


subject: CHEBI:5613

object_name: Long Term Psychologic Disorders


subject: CHEBI:10119

subject_name: Ziprasidone


subject: CHEBI:10119


subject: CHEMBL.COMPOUND:CHEMBL1201582

subject_name: TETANUS IMMUNE GLOBULIN

object_name: tetanus


subject: UMLS:C0305058

subject_name: tetanus immune globulin, human


subject: UMLS:C4048265

subject_name: tetanus immune globulin


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:5778

object_name: metabolic syndrome X


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: CHEBI:9150

subject_name: Simvastatin

object_name: schizophreniform disorder


subject: CHEBI:9150

object_name: psychosis


subject: CHEBI:9150

object_name: Nonorganic psychosis


subject: UNII:98DE7VN88D

subject_name: huMov 19

object_name: ovarian cancer


subject: UNII:98DE7VN88D

object_name: ovarian neoplasm


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: PUBCHEM.COMPOUND:54681072

subject_name: Omadacycline

object_name: acute pyelonephritis


subject: UNII:090IP5RV8F


subject: GTOPDB:9674

subject_name: olaptesed pegol

object_name: Metastatic malignant neoplasm to pancreas


subject: UNII:MTM792B442

subject_name: OLAPTESED PEGOL


subject: GTOPDB:13497

subject_name: axatilimab

object_name: myelofibrosis


subject: CHEMBL.COMPOUND:CHEMBL4594608

subject_name: AXATILIMAB


subject: UMLS:C4733597


subject: UNII:08AN7WA2G0

subject_name: TRIPTORELIN PAMOATE

object_name: prostate carcinoma


subject: UNII:08AN7WA2G0

object_name: prostate cancer


subject: UMLS:C1145204

subject_name: INJECTION, TRIPTORELIN PAMOATE, 3.75 MG ADMINISTERED


subject: UMLS:C1145204


subject: UMLS:C0112708

subject_name: Trelstar


subject: UMLS:C0112708


subject: CHEBI:167309

subject_name: Methadone

object_name: chronic pain (diagnosis)


subject: CHEBI:167309

object_name: Chronic pain


subject: CHEBI:6931

subject_name: Midazolam

object_name: cesarean section; complications


subject: UNII:41XGO0VS1U

object_name: metastatic colorectal cancer


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: malignant soft tissue neoplasm


subject: UNII:52CMI0WC3Y

object_name: sarcoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Secondary malignant neoplasm of lung


subject: UNII:6XC1PAD3KF

object_name: Tumor necrosis


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:49668

subject_name: Gefitinib

object_name: esophageal adenocarcinoma


subject: CHEBI:49668

object_name: cervical adenocarcinoma


subject: CHEBI:49668

object_name: adenocarcinoma


subject: CHEBI:49668

object_name: bile duct adenocarcinoma


subject: CHEBI:49668

object_name: gastric adenocarcinoma


subject: CHEBI:73520

subject_name: Ile-His

object_name: hepatitis B


subject: CHEBI:73520

object_name: poliomyelitis


subject: CHEBI:73520

object_name: diphtheria


subject: CHEBI:73520

object_name: tetanus


subject: CHEBI:184581

subject_name: IH


subject: CHEBI:184581


subject: CHEBI:184581


subject: CHEBI:184581


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine


subject: UMLS:C0728976


subject: UMLS:C0728976


subject: UMLS:C0728976


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: UNII:69VKY8P7EA

object_name: colorectal cancer


subject: UNII:69VKY8P7EA

object_name: colorectal carcinoma


subject: UNII:69VKY8P7EA

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:69VKY8P7EA

object_name: Stomach cancer


subject: UNII:69VKY8P7EA

object_name: gastric cancer


subject: UMLS:C2004126

subject_name: TKI 258


subject: UMLS:C2004126


subject: UMLS:C2004126


subject: UMLS:C2004126


subject: UMLS:C2004126


subject: CHEBI:91899


subject: CHEBI:91899

object_name: Cacosmia


subject: CHEBI:91899

object_name: Parosmia


subject: CHEBI:91899

object_name: anosmia


subject: CHEBI:91899

object_name: Anosmia, CTCAE


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: UMLS:C5553091

object_name: Metastatic non-small cell lung cancer


subject: CHEMBL.COMPOUND:CHEMBL2108102

subject_name: ST. JOHN'S WORT

object_name: Drug Interactions


subject: UMLS:C1565751

object_name: type 2 diabetes mellitus


subject: UMLS:C2346514

subject_name: Intranasal Ketamine

object_name: abscess


subject: DRUGBANK:DB14222

subject_name: Bifidobacterium longum infantis

object_name: urinary tract infection


subject: DRUGBANK:DB14222

object_name: Recurrent urinary tract infections


subject: DRUGBANK:DB14222

object_name: Antibiotic resistant infection


subject: UMLS:C4019097

subject_name: herbal medicines bifidobacterium infantis


subject: UMLS:C4019097


subject: UMLS:C4019097


subject: UMLS:C1706653

subject_name: Aminoflavone Prodrug AFP464

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C1706653

object_name: Recurrent ovarian cancer


subject: UMLS:C1706653

object_name: Renal cell carcinoma recurrent


subject: UMLS:C1706653

object_name: Renal cancer recurrent


subject: UMLS:C1706653

object_name: recurrent primary peritoneal cavity cancer


subject: UMLS:C1706653

object_name: Breast cancer recurrent


subject: UMLS:C1706653

object_name: stage IV primary peritoneal cavity cancer


subject: UMLS:C1706653

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1706653

object_name: Ovarian cancer stage IV


subject: UMLS:C1706653

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C1706653

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C1706653

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C1706653

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C1706653

object_name: Carcinoma breast stage IV


subject: UMLS:C1706653

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1706653

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1706653

object_name: male breast carcinoma


subject: CHEBI:119915

subject_name: Fentanyl

object_name: tonsillitis


subject: CHEBI:119915

object_name: Pain, Procedural


subject: CHEBI:119915

object_name: obstructive sleep apnea syndrome


subject: CHEBI:5790

subject_name: Hydromorphone


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:167309

subject_name: Methadone


subject: CHEBI:167309


subject: CHEBI:167309


subject: MESH:D002214

subject_name: Capsules

object_name: Pruritus, CTCAE


subject: MESH:D002214

object_name: Pruritus


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Abnormal macular morphology


subject: UNII:15C2VL427D

subject_name: Aflibercept


subject: UNII:2H1PA8H1EN

subject_name: Pegaptanib


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Sphenopalatine Neuralgia


subject: CHEBI:6456

object_name: Migraine in children


subject: CHEBI:6456

object_name: Migraine in adolescence


subject: UMLS:C5417784

object_name: Stage III Lung Cancer


subject: CHEBI:10034

subject_name: warfarin sodium

object_name: Cerebral venous thrombosis


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:145365

subject_name: Crenolanib

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:145365

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: glaucoma


subject: CHEBI:15927

object_name: Glaucoma, CTCAE


subject: CHEBI:174615

object_name: High Risk Neuroblastoma


subject: CHEBI:28901

subject_name: Busulfan


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4305

subject_name: dacarbazine


subject: UNII:7SQY4ZUD30

subject_name: Dinutuximab


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:36373

subject_name: vindesine


subject: UMLS:C4053589

subject_name: Wnt Signaling Inhibitor SM04755

object_name: Tendinopathy


subject: GTOPDB:9195

subject_name: clazakizumab

object_name: rheumatoid arthritis


subject: UNII:4S38Z8RA9O


subject: UMLS:C2830049


subject: UMLS:C4732931

subject_name: Sienna+

object_name: rectal carcinoma


subject: UMLS:C4732931

object_name: rectal cancer


subject: UMLS:C4732931

object_name: Childhood Rectal Carcinoma


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Torticollis


subject: GTOPDB:9623

object_name: ulcerative colitis


subject: UNII:1PQB4AA2CT


subject: UMLS:C4705543


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UNII:7CND0TX59N

subject_name: Potassium octanoate

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:25646

subject_name: octanoate


subject: CHEBI:28837

subject_name: Caprylic acid


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:41977

subject_name: Daunorubicin


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Oligoarthritis


subject: CHEBI:42944

subject_name: Galantamine

object_name: Addiction


subject: UMLS:C1707048

subject_name: broccoli sprout extract

object_name: Stage 0 Bladder Carcinoma


subject: UMLS:C1707048

object_name: Stage I Bladder Cancer AJCC v8


subject: UMLS:C1707048

object_name: Stage I Carcinoma of Bladder


subject: UMLS:C1707048

object_name: Stage II Bladder Cancer AJCC v6 and v7


subject: UMLS:C1707048

object_name: Stage II Bladder Cancer AJCC v8


subject: UMLS:C1707048

object_name: Bladder cancer recurrent


subject: UMLS:C1707048

object_name: transitional cell carcinoma


subject: CHEBI:60654

subject_name: valproate

object_name: schizophrenia


subject: UMLS:C4733404

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C4733404

object_name: obesity


subject: UMLS:C4733404

object_name: Obesity, CTCAE


subject: CHEBI:74947

subject_name: Thalidomide

object_name: uveitis


subject: CHEBI:74947

object_name: Uveitis, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4802180

subject_name: RECOMBINANT HUMAN THROMBOPOIETIN

object_name: autoimmune thrombocytopenia


subject: CHEMBL.COMPOUND:CHEMBL4802180

object_name: autoimmune thrombocytopenic purpura


subject: CHEMBL.COMPOUND:CHEMBL4802180

object_name: purpura


subject: CHEMBL.COMPOUND:CHEMBL4802180

object_name: Purpura, CTCAE


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin


subject: UMLS:C0392939


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:135905

subject_name: Terlipressin

object_name: Blood Loss


subject: UNII:AJ212MS2O2

object_name: Drug Interactions


subject: UNII:AJ212MS2O2

object_name: Adverse drug interaction


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: UMLS:C4692289

subject_name: erenumab-aooe

object_name: migraine


subject: UMLS:C4692289

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:49960

subject_name: Vandetanib

object_name: colorectal cancer


subject: CHEBI:49960

object_name: colorectal carcinoma


subject: CHEBI:49960

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: nephrotic syndrome


subject: CHEBI:39548

object_name: Nephrotic Syndrome, CTCAE


subject: UMLS:C4727040

subject_name: Axl/Mer Inhibitor INCB081776

object_name: head and neck squamous cell carcinoma


subject: GTOPDB:11827

subject_name: telitacicept

object_name: IgA Nephropathy


subject: CHEMBL.COMPOUND:CHEMBL5095293

subject_name: TELITACICEPT


subject: UMLS:C5238006


subject: UNII:7DP3NTV15T

subject_name: BLEOMYCIN SULFATE

object_name: Hodgkin Disease


subject: UNII:7DP3NTV15T

object_name: Adult Hodgkin Lymphoma


subject: UNII:7DP3NTV15T

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: opioid abuse


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:5551

subject_name: Guaifenesin

object_name: Intrascapular pain


subject: CHEBI:5551

object_name: Upper back pain


subject: CHEBI:8461

subject_name: Promethazine

object_name: Nausea, CTCAE_5


subject: CHEBI:8461

object_name: Nausea


subject: CHEBI:8461

object_name: Nausea, CTCAE_3


subject: CHEBI:87681

subject_name: Ranolazine

object_name: persistent atrial fibrillation


subject: CHEBI:87681

object_name: Persistent Atrial Fibrillation by ECG Finding


subject: CHEBI:174615

object_name: severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency


subject: CHEBI:28901

subject_name: Busulfan


subject: UNII:HW3H7D91F6

subject_name: Pegademase


subject: CHEBI:145371

subject_name: Binimetinib

object_name: colorectal cancer


subject: CHEBI:145371

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:145371

object_name: Metastatic Uveal Melanoma


subject: CHEBI:77562

subject_name: rac-crizotinib


subject: CHEBI:77562


subject: CHEBI:77562

object_name: skin melanoma


subject: CHEBI:77562


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:233324

subject_name: Darovasertib


subject: CHEBI:233324

object_name: colorectal carcinoma


subject: CHEBI:233324


subject: CHEBI:233324

object_name: melanoma


subject: CHEBI:233324


subject: CHEBI:233324


subject: UMLS:C4086759

subject_name: PKC Inhibitor IDE196


subject: UMLS:C4086759


subject: UMLS:C4086759


subject: UMLS:C4086759


subject: UMLS:C4086759


subject: UMLS:C4086759


subject: CHEBI:231679

subject_name: ipilimumab

object_name: colon carcinoma


subject: CHEBI:231679

object_name: colon cancer


subject: DRUGBANK:DB18696

object_name: congenital alveolar dysplasia


subject: UMLS:C0771129

subject_name: 0.225 % sodium chloride

object_name: Hematoma, Subdural, Chronic


subject: PUBCHEM.COMPOUND:2791

subject_name: Clobetasol propionate

object_name: atopic eczema


subject: CHEBI:205919

subject_name: Clobetasol


subject: CHEBI:68855

subject_name: Ioflupane I-123

object_name: Parkinson disease


subject: UMLS:C1276996

subject_name: Atypical antipsychotic

object_name: schizophrenia


subject: UMLS:C1276996

object_name: endogenous depression


subject: UMLS:C1276996

object_name: major depressive disorder


subject: CHEBI:66964

subject_name: Dronabinol

object_name: post operative nausea and vomiting


subject: PUBCHEM.COMPOUND:66586232

object_name: canker sore


subject: PUBCHEM.COMPOUND:66586232

object_name: Minor oral aphthous ulceration


subject: PUBCHEM.COMPOUND:66586232

object_name: aphthous stomatitis


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: CHEBI:3614


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: long QT syndrome 1


subject: UMLS:C4727249

subject_name: Indium In 111 Minigastrin Analog CP04

object_name: familial medullary thyroid carcinoma


subject: UMLS:C4727249

object_name: medullary thyroid gland carcinoma


subject: UMLS:C4727792

subject_name: Gelaspan


subject: UMLS:C4727792


subject: CHEBI:24261

subject_name: glucocorticoid

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:15765

subject_name: Levodopa

object_name: Dyskinesia


subject: CHEBI:15765

object_name: movement disorder


subject: UMLS:C2347432

object_name: Xerostomia following radiotherapy


subject: UMLS:C2347432

object_name: Neck Carcinoma


subject: UMLS:C2347432

object_name: head and neck neoplasm


subject: UMLS:C2347432

object_name: head and neck cancer


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: acute myeloid leukemia by FAB classification


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: acute myeloid leukemia


subject: UMLS:C2346454


subject: UMLS:C2346454


subject: CHEBI:31355

subject_name: Carboplatin

object_name: skin melanoma


subject: CHEBI:35469

subject_name: antidepressant

object_name: bulimia nervosa


subject: UMLS:C0003289

subject_name: Antidepressive Agents


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)


subject: UMLS:C5206707

subject_name: Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01

object_name: pancreatic neoplasm


subject: UMLS:C5206707

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5206707

object_name: malignant pancreatic neoplasm


subject: CHEBI:35677

subject_name: Betahistine

object_name: schizoaffective disorder


subject: CHEBI:35677

object_name: schizophrenia 18


subject: CHEBI:35677

object_name: schizophrenia


subject: CHEBI:35677

object_name: schizophreniform disorder


subject: CHEBI:35677

object_name: pervasive developmental disorder


subject: CHEBI:35677

object_name: autism


subject: CHEBI:35677

object_name: autism spectrum disorder


subject: CHEBI:35677

object_name: bipolar I disorder


subject: CHEBI:28838

subject_name: Lutein

object_name: multiple sclerosis


subject: CHEBI:174615

object_name: adult germ cell tumor


subject: CHEBI:174615

object_name: germ cell tumor


subject: CHEBI:174615

object_name: childhood germ cell tumor


subject: CHEBI:174615

object_name: Germ Cell Cancer


subject: CHEBI:174615

object_name: rhabdoid tumor


subject: CHEBI:174615

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:174615

object_name: clear cell renal carcinoma


subject: CHEBI:174615

object_name: renal cell adenocarcinoma


subject: CHEBI:174615

object_name: renal cell carcinoma


subject: CHEBI:174615

object_name: liver neoplasm


subject: CHEBI:174615

object_name: digestive system neoplasm


subject: CHEBI:174615

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:174615

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:174615

object_name: clear cell adenocarcinoma


subject: CHEBI:174615

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:174615

object_name: rhabdomyosarcoma


subject: CHEBI:174615

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:174615

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:174615

object_name: melanoma


subject: CHEBI:28901

subject_name: Busulfan

object_name: adult germ cell tumor


subject: CHEBI:28901

object_name: germ cell tumor


subject: CHEBI:28901

object_name: childhood germ cell tumor


subject: CHEBI:28901

object_name: Germ Cell Cancer


subject: CHEBI:28901

object_name: rhabdoid tumor


subject: CHEBI:28901

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:28901

object_name: clear cell renal carcinoma


subject: CHEBI:28901

object_name: renal cell adenocarcinoma


subject: CHEBI:28901

object_name: renal cell carcinoma


subject: CHEBI:28901

object_name: liver neoplasm


subject: CHEBI:28901

object_name: digestive system neoplasm


subject: CHEBI:28901

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:28901

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:28901

object_name: clear cell adenocarcinoma


subject: CHEBI:28901

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:28901

object_name: rhabdomyosarcoma


subject: CHEBI:28901

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:28901

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:28901

object_name: melanoma


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: adult germ cell tumor


subject: UNII:3A189DH42V

object_name: germ cell tumor


subject: UNII:3A189DH42V

object_name: childhood germ cell tumor


subject: UNII:3A189DH42V

object_name: Germ Cell Cancer


subject: UNII:3A189DH42V

object_name: rhabdoid tumor


subject: UNII:3A189DH42V

object_name: nonpapillary renal cell carcinoma


subject: UNII:3A189DH42V

object_name: clear cell renal carcinoma


subject: UNII:3A189DH42V

object_name: renal cell adenocarcinoma


subject: UNII:3A189DH42V

object_name: liver neoplasm


subject: UNII:3A189DH42V

object_name: nephroblastoma


subject: UNII:3A189DH42V

object_name: Wilms tumor


subject: UNII:3A189DH42V

object_name: childhood kidney Wilms tumor


subject: UNII:3A189DH42V

object_name: digestive system neoplasm


subject: UNII:3A189DH42V

object_name: Neoplasm of the gastrointestinal tract


subject: UNII:3A189DH42V

object_name: endometrial clear cell adenocarcinoma


subject: UNII:3A189DH42V

object_name: clear cell adenocarcinoma


subject: UNII:3A189DH42V

object_name: Ewing sarcoma


subject: UNII:3A189DH42V

object_name: Adult Rhabdomyosarcoma


subject: UNII:3A189DH42V

object_name: rhabdomyosarcoma


subject: UNII:3A189DH42V

object_name: Childhood Rhabdomyosarcoma


subject: UNII:3A189DH42V

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:3A189DH42V

object_name: Childhood Neuroblastoma


subject: UNII:3A189DH42V

object_name: neuroblastoma


subject: UNII:3A189DH42V

object_name: melanoma


subject: PUBCHEM.COMPOUND:3367

object_name: adult germ cell tumor


subject: PUBCHEM.COMPOUND:3367

object_name: germ cell tumor


subject: PUBCHEM.COMPOUND:3367

object_name: childhood germ cell tumor


subject: PUBCHEM.COMPOUND:3367

object_name: Germ Cell Cancer


subject: PUBCHEM.COMPOUND:3367

object_name: rhabdoid tumor


subject: PUBCHEM.COMPOUND:3367

object_name: liver neoplasm


subject: PUBCHEM.COMPOUND:3367

object_name: nephroblastoma


subject: PUBCHEM.COMPOUND:3367

object_name: Wilms tumor


subject: PUBCHEM.COMPOUND:3367

object_name: childhood kidney Wilms tumor


subject: PUBCHEM.COMPOUND:3367

object_name: digestive system neoplasm


subject: PUBCHEM.COMPOUND:3367

object_name: Neoplasm of the gastrointestinal tract


subject: PUBCHEM.COMPOUND:3367

object_name: endometrial clear cell adenocarcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: clear cell adenocarcinoma


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:82339

object_name: clear cell renal carcinoma


subject: CHEBI:82339

object_name: renal cell adenocarcinoma


subject: CHEBI:82339

object_name: renal cell carcinoma


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:82339

object_name: rhabdomyosarcoma


subject: CHEBI:82339

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:82339

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:28876

subject_name: Melphalan

object_name: adult germ cell tumor


subject: CHEBI:28876

object_name: germ cell tumor


subject: CHEBI:28876

object_name: childhood germ cell tumor


subject: CHEBI:28876

object_name: Germ Cell Cancer


subject: CHEBI:28876

object_name: rhabdoid tumor


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876

object_name: liver neoplasm


subject: CHEBI:28876

object_name: digestive system neoplasm


subject: CHEBI:28876

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:28876

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:28876

object_name: clear cell adenocarcinoma


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168

object_name: nephroblastoma


subject: CHEBI:9168

object_name: Wilms tumor


subject: CHEBI:9168

object_name: childhood kidney Wilms tumor


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168

object_name: Ewing sarcoma


subject: CHEBI:9168

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:9168

object_name: rhabdomyosarcoma


subject: CHEBI:9168

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:9168

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:9168

object_name: Childhood Neuroblastoma


subject: CHEBI:9168

object_name: neuroblastoma


subject: CHEBI:9168

object_name: melanoma


subject: UMLS:C4287773

subject_name: VLP-encapsulated TLR9 Agonist CMP-001

object_name: adult lymphoma


subject: UMLS:C4287773

object_name: lymphoma


subject: UMLS:C4287773

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135512673

object_name: Childhood Hodgkin Lymphoma


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: type 1 diabetes mellitus 1


subject: UNII:91X1KLU43E

object_name: type 1 diabetes mellitus


subject: UMLS:C5239057

subject_name: Nicotine Replacement Agent

object_name: nicotine dependence


subject: CHEBI:9150

subject_name: Simvastatin

object_name: heart failure


subject: CHEBI:9150

object_name: Heart Failure, CTCAE


subject: CHEBI:31687

subject_name: Idebenone

object_name: Duchenne muscular dystrophy


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: hemophagocytic syndrome


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:41948

subject_name: Eflornithine

object_name: medulloblastoma


subject: CHEBI:41948

object_name: childhood medulloblastoma


subject: CHEBI:41948

object_name: adult medulloblastoma


subject: UMLS:C5702998

subject_name: FANG

object_name: rheumatoid arthritis


subject: UMLS:C5553099

subject_name: Gemogenovatucel-T


subject: CHEBI:61080

subject_name: Romidepsin

object_name: HIV infection


subject: UMLS:C0963679


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Sepsis


subject: UMLS:C0445115

object_name: Sepsis, CTCAE


subject: UMLS:C0445115

object_name: septic shock


subject: UMLS:C0445115

object_name: acute kidney failure


subject: UMLS:C0445115

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C0073384

subject_name: Ringer's acetate


subject: UMLS:C0073384


subject: UMLS:C0073384


subject: UMLS:C0073384


subject: UMLS:C0073384


subject: CHEBI:231347

subject_name: Triapine

object_name: Recurrent Astrocytoma, IDH-Mutant


subject: CHEBI:231347

object_name: Recurrent Astrocytoma, IDH-Mutant, Grade 3


subject: CHEBI:231347

object_name: Recurrent Astrocytoma, IDH-Mutant, Grade 4


subject: CHEBI:231347

object_name: astrocytoma, IDH-mutant, grade 2


subject: UMLS:C5432235

subject_name: Pegylated Recombinant Human Arginase I

object_name: liver carcinoma


subject: UMLS:C5432235

object_name: childhood neoplasm


subject: UMLS:C5432235

object_name: neoplastic syndrome


subject: UMLS:C5432235

object_name: cancer or benign tumor


subject: UMLS:C5432235

object_name: neoplasm


subject: GTOPDB:12990

subject_name: sintilimab

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: GTOPDB:12990

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: MESH:C000722208

subject_name: LY3295668 erbumine

object_name: Carcinoma breast stage IV


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:95021

subject_name: pemetrexed

object_name: biliary tract cancer


subject: UNII:CJ1PL0TE6J

subject_name: Nidufexor

object_name: diabetic kidney disease


subject: UMLS:C3248676

subject_name: ONDANSETRON, ORAL, 4 MG (FOR CIRCUMSTANCES FALLING UNDER THE MEDICARE STATUTE, USE HCPCS Q CODE)

object_name: hypotension


subject: UMLS:C3248676

object_name: Hypotension, CTCAE


subject: UMLS:C3248676

object_name: anesthesia; adverse effect, spinal and epidural


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:32139

object_name: no feeling or sensation of skin


subject: CHEBI:32139

object_name: Sensory Loss


subject: CHEBI:32139

object_name: Infiltration


subject: UNII:6ZA31Y954Z

subject_name: Brodalumab

object_name: Acne inversa


subject: CHEBI:9168

subject_name: Sirolimus

object_name: brain aneurysm


subject: UNII:Q6U6J48BWY

subject_name: Imiglucerase

object_name: Gaucher disease type III


subject: UNII:Q6U6J48BWY

object_name: Gaucher disease type I


subject: PR:000007867

subject_name: lysosomal acid glucosylceramidase


subject: PR:000007867


subject: UNII:BLP1XA3FZA

subject_name: Venglustat


subject: UNII:BLP1XA3FZA


subject: CHEBI:6801

subject_name: Metformin

object_name: diffuse large B-cell lymphoma


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Refractory Central Nervous System Lymphoma


subject: CHEBI:63791

object_name: Recurrent Central Nervous System Lymphoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C4044446

object_name: Crohn disease


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: pancreatic neoplasm


subject: UNII:9G6U5L461Q

object_name: exocrine pancreatic carcinoma


subject: UNII:9G6U5L461Q

object_name: malignant pancreatic neoplasm


subject: CHEBI:8435

subject_name: Prochlorperazine

object_name: acute mountain sickness


subject: CHEBI:8435

object_name: ablepharon macrostomia syndrome


subject: PR:000023149

subject_name: maltose/maltodextrin transport system permease protein MalG

object_name: Pediculosis


subject: UniProtKB:P68183

subject_name: MALG_ECOLI Maltose/maltodextrin transport system permease protein MalG (sprot)


subject: CHEBI:141474

subject_name: Malathion


subject: UMLS:C5854635

subject_name: Hpk1 Inhibitor BGB-26808

object_name: Childhood Solid Neoplasm


subject: UMLS:C5854635

object_name: Adult Solid Neoplasm


subject: UMLS:C5854635

object_name: Solid Neoplasm


subject: UMLS:C5854635

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Advanced Melanoma


subject: UMLS:C5234034

subject_name: Tepezza

object_name: diffuse cutaneous systemic sclerosis


subject: UMLS:C5234034

object_name: diffuse scleroderma


subject: UMLS:C5854337

subject_name: PLS 240

object_name: end stage renal failure


subject: UMLS:C5854337

object_name: Chronic uremia


subject: UMLS:C5417984

subject_name: MEK Inhibitor HL-085

object_name: colorectal cancer


subject: UMLS:C5417984

object_name: colorectal carcinoma


subject: CHEBI:63637

subject_name: Vemurafenib


subject: UMLS:C0359156

subject_name: Thymoglobulin

object_name: lymphoblastic lymphoma


subject: UMLS:C0359156

object_name: Adult Lymphoblastic Lymphoma


subject: UMLS:C0359156

object_name: Childhood Lymphoblastic Lymphoma


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: post-traumatic stress disorder


subject: UMLS:C0003015

object_name: pneumonia


subject: UMLS:C0003015

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C3536837

subject_name: Angiotensin Converting Enzyme Inhibitor [EPC]


subject: UMLS:C3536837


subject: CHEBI:6503

subject_name: LISINOPRIL


subject: CHEBI:6503


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: UMLS:C5963450


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: varicose veins


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:78770

subject_name: ethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:2724258

subject_name: Polyethylene glycol monododecyl ether


subject: PUBCHEM.COMPOUND:76459

subject_name: Heptaethylene glycol monododecyl ether


subject: CHEBI:46859

subject_name: Polidocanol


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: Hypercholesterolemia


subject: CHEBI:151315

subject_name: Heparin

object_name: Burn injury


subject: KEGG.COMPOUND:C00374


subject: CHEMBL.COMPOUND:CHEMBL2108924

subject_name: CINNAMON

object_name: Insulin resistance


subject: CHEMBL.COMPOUND:CHEMBL2108924

object_name: Pediatric Obesity


subject: CHEMBL.COMPOUND:CHEMBL2108924

object_name: Insulin Sensitivity


subject: UMLS:C0939899

subject_name: cinnamon preparation


subject: UMLS:C0939899


subject: UMLS:C0939899


subject: CHEBI:60654

subject_name: valproate

object_name: bipolar depression


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:78539

subject_name: Zofenopril

object_name: hypertension


subject: CHEBI:78539

object_name: Hypertension, CTCAE


subject: UMLS:C0360032

subject_name: EMLA Cream

object_name: frozen shoulder


subject: UMLS:C0360032

object_name: bursitis


subject: UMLS:C1508867

subject_name: MYCOPHENOLIC ACID, ORAL, 180 MG ADMINISTERED

object_name: myasthenia gravis


subject: UMLS:C1508867

object_name: Myasthenia Gravis, CTCAE


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: dysthymic disorder


subject: UMLS:C5707546

subject_name: Technetium Tc-99m DARPinG3

object_name: HER2 positive breast carcinoma


subject: UMLS:C5707546

object_name: Females


subject: UMLS:C0662900

object_name: Neck Carcinoma


subject: UMLS:C0662900

object_name: head and neck neoplasm


subject: UMLS:C0662900

object_name: head and neck cancer


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:125354


subject: CHEBI:125354


subject: CHEBI:8378

subject_name: Prednisolone

object_name: nephrotic syndrome of childhood - steroid sensitive


subject: CHEBI:195327

subject_name: Hydroxypropyl betadex

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:76211403

subject_name: Eravacycline

object_name: complicated appendicitis


subject: UNII:07896928ZC


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Alkylating Agent-Related Acute Myeloid Leukemia


subject: CHEBI:63791

object_name: Lymphomatous Involvement of Non-Cutaneous Extranodal Site


subject: CHEBI:63791

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:63791

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: CHEBI:63791

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:63791

object_name: T-cell large granular lymphocyte leukemia


subject: CHEBI:63791

object_name: refractory hairy cell leukemia


subject: CHEBI:63791

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:63791

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:63791

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:63791

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:63791

object_name: prolymphocytic leukemia


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Surgical incision wound (morphologic abnormality)


subject: UMLS:C0445115

object_name: Surgical wound


subject: UMLS:C0445115

object_name: physical trauma to surgical incision (history)


subject: UMLS:C0445115

object_name: Acute Pain


subject: CHEBI:567361

subject_name: Cladribine

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:AF75XOF6W3

object_name: non-Hodgkin lymphoma


subject: UNII:AF75XOF6W3

object_name: Hodgkin Disease


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: CHEBI:79068

subject_name: Crocin

object_name: age-related macular degeneration


subject: UMLS:C3696061

subject_name: saffron extract


subject: UMLS:C0162753

subject_name: saffron stain


subject: GTOPDB:2479

subject_name: HCl

object_name: cancer pain


subject: UMLS:C1512523

subject_name: hydrochloride


subject: UMLS:C0443985

subject_name: Flinders medical centre-7 marker


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: UMLS:C0009871

subject_name: Contraceptive Agents

object_name: Androgen excess


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate

object_name: colon carcinoma


subject: CHEBI:32296

object_name: colorectal cancer


subject: CHEBI:32296

object_name: colon cancer


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: allergic asthma


subject: CHEBI:43636


subject: UMLS:C3273002

subject_name: Anti-prolactin Receptor Antibody LFA102

object_name: Carcinoma breast stage IV


subject: UMLS:C3273002

object_name: castration-resistant prostate carcinoma


subject: UMLS:C3273002

object_name: uterine fibroid


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Neck Carcinoma


subject: UMLS:C0013227

object_name: head and neck neoplasm


subject: UMLS:C0013227

object_name: head and neck cancer


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:33330

subject_name: scandium atom

object_name: Childhood Solid Neoplasm


subject: CHEBI:33330

object_name: Adult Solid Neoplasm


subject: CHEBI:33330

object_name: Solid Neoplasm


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000007182


subject: PR:000007182


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: PR:000050188


subject: PR:000050188


subject: CHEBI:31401

subject_name: Cilostazol

object_name: Recurrent stroke


subject: CHEBI:31401

object_name: transient ischemic attack


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib


subject: CHEBI:85164


subject: CHEBI:17026

subject_name: Progesterone

object_name: Normal puberty


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Childhood Gastrointestinal Stromal Tumor


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: plasma cell myeloma


subject: UMLS:C2984033

object_name: Advanced breast cancer


subject: CHEBI:71219

object_name: Liposarcoma metastatic


subject: UMLS:C3494178

subject_name: Intravenous Immunoglobulins, Human

object_name: autoimmune thrombocytopenia


subject: UMLS:C3494178

object_name: thrombocytopenia due to immune destruction


subject: UMLS:C3494178

object_name: autoimmune thrombocytopenic purpura


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: COVID-19 respiratory infection


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: UMLS:C0812987

subject_name: Chemotherapy Drugs Adminstered

object_name: Treatment related secondary malignancy


subject: CHEBI:74947

subject_name: Thalidomide


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol


subject: UMLS:C2347328

subject_name: sirolimus protein-bound particles

object_name: neuroendocrine neoplasm


subject: UMLS:C2347328

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: UMLS:C2347328

object_name: pancreatic neuroendocrine tumor


subject: UMLS:C2347328

object_name: Neuroendocrine tumor of pancreas


subject: UMLS:C2347328

object_name: lung neuroendocrine neoplasm


subject: CHEBI:74947

object_name: multicentric Castleman disease


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:8382

subject_name: Prednisone


subject: UMLS:C2604163

object_name: Parkinson disease


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:231614

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:124939

subject_name: Rigosertib


subject: CHEBI:124939

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:124939


subject: CHEBI:124939

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:124939

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:124939


subject: CHEBI:124939

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:124939

object_name: esophageal adenocarcinoma


subject: CHEBI:124939

object_name: lung adenocarcinoma


subject: CHEBI:124939

object_name: cervical adenocarcinoma


subject: CHEBI:124939

object_name: adenocarcinoma


subject: CHEBI:124939

object_name: bile duct adenocarcinoma


subject: CHEBI:124939

object_name: gastric adenocarcinoma


subject: CHEBI:124939

object_name: non-small cell lung carcinoma


subject: UMLS:C4521107

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4521107

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:166625217

subject_name: MOTIXAFORTIDE


subject: PUBCHEM.COMPOUND:166625217


subject: UNII:FWL2263R77

subject_name: Zoliflodacin

object_name: gonorrhea


subject: UMLS:C5417905

subject_name: Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UMLS:C5417905

object_name: skin melanoma


subject: UMLS:C0939884

subject_name: Cinnamomum camphora, camphor, Homeopathic preparation

object_name: common cold


subject: CHEBI:36773

subject_name: camphor


subject: PUBCHEM.COMPOUND:2758

subject_name: cineole


subject: UNII:0WA1B15A1Z

subject_name: Polaprezinc

object_name: Periodontal Index


subject: UMLS:C0078737


subject: MESH:D003487

subject_name: Cyanoacrylates

object_name: Surgical wound, healed


subject: MESH:D003487

object_name: Post-Operative Pain


subject: CHEBI:78320

subject_name: Lactic acid

object_name: hypertriglyceridemia


subject: CHEBI:78320

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:92998

subject_name: Guanabenz


subject: CHEBI:92998


subject: UMLS:C0353714

subject_name: Peritoneal dialysis solution (product)


subject: UMLS:C0353714


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: alcohol abuse


subject: DRUGBANK:DB14336

subject_name: Angelica sinensis root

object_name: Acute Ischemic Stroke


subject: DRUGBANK:DB14336

object_name: Ischemic stroke


subject: CHEBI:64312

subject_name: Memantine

object_name: Central Nervous System Carcinoma


subject: CHEBI:15940

subject_name: Niacin

object_name: peripheral vascular disease


subject: CHEBI:15940

object_name: peripheral arterial disease


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: BRAF mutation-related tumors


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:73611

subject_name: Met-Gly

object_name: stroke disorder


subject: CHEBI:73611

object_name: cerebrovascular disorder


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Corneal graft failure


subject: CHEBI:23965

subject_name: estradiol

object_name: Atrophic


subject: CHEBI:18220

subject_name: Isoflavone


subject: CHEBI:6456

subject_name: Lidocaine

object_name: cholelithiasis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: senile cataract


subject: CHEBI:41879

object_name: nuclear cataract


subject: CHEBI:41879

object_name: Embryonal nuclear cataract (disorder)


subject: CHEBI:41879

object_name: Ocular pain


subject: CHEBI:41879

object_name: corneal edema


subject: CHEBI:41879

object_name: Corneal defect


subject: CHEBI:41879

object_name: Cortical, lamellar, or zonular nonsenile cataract


subject: CHEBI:41879

object_name: cortical cataract


subject: UMLS:C4086994

object_name: recurrent respiratory papillomatosis


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: cognitive disorder


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: oligodendroglioma


subject: PUBCHEM.COMPOUND:70789204

object_name: oligoastrocytoma


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Muscle Invasive Bladder Carcinoma


subject: UNII:KXG2PJ551I

object_name: Stage II Bladder Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: infiltrating renal pelvis/ureter urothelial carcinoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: UMLS:C2976304

object_name: hepatitis C


subject: UMLS:C2976304

object_name: chronic hepatitis C virus infection


subject: UNII:H1396W7D1H

subject_name: FAVEZELIMAB

object_name: melanoma


subject: UMLS:C4684393

subject_name: Favezelimab


subject: UMLS:C5205034


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Cardiomegaly


subject: CHEBI:6801

subject_name: Metformin


subject: UNII:0R1HN52K0N

subject_name: Padsevonil

object_name: epilepsy


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: pediatric lymphoma


subject: CHEBI:404903

subject_name: Ertapenem

object_name: end stage renal failure


subject: CHEBI:404903

object_name: Chronic uremia


subject: UMLS:C0013230

subject_name: Investigational New Drugs

object_name: Childhood Breast Carcinoma


subject: UMLS:C0013230

object_name: breast carcinoma


subject: UMLS:C0013230

object_name: breast cancer


subject: CHEBI:93776

subject_name: Pevonedistat

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:93776

object_name: myoclonic dystonia 11


subject: CHEBI:63606

subject_name: Levoleucovorin

object_name: pervasive developmental disorder


subject: CHEBI:63606

object_name: autism


subject: CHEBI:63606

object_name: autism spectrum disorder


subject: CHEBI:63606

object_name: language disorder


subject: CHEBI:7772

subject_name: omeprazole

object_name: neoplasm


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:188074


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:10033

subject_name: Warfarin


subject: UNII:TT0V5JLG5B

subject_name: Avacincaptad pegol

object_name: Geographic atrophy


subject: UNII:TT0V5JLG5B

object_name: macular degeneration


subject: UNII:TT0V5JLG5B

object_name: age-related macular degeneration


subject: UNII:TT0V5JLG5B

object_name: retinitis pigmentosa 30


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: anemia


subject: UMLS:C0301532

object_name: Anemia, CTCAE


subject: UMLS:C3714835

subject_name: Multivitamin Drug Class


subject: UMLS:C3714835


subject: UMLS:C5706430

subject_name: BCR-ABL Inhibitor HS-10382

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:233593

subject_name: Flumatinib

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:233593

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:66586232

object_name: Peritoneal dialysis catheter exit site infection


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:63660

object_name: chronic kidney disease


subject: CHEBI:63660

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: MESH:C000592463

object_name: tuberculosis


subject: CHEBI:201441

subject_name: GATIFLOXACIN

object_name: typhoid fever


subject: CHEBI:5280

subject_name: Gatifloxacin


subject: UMLS:C4733962

subject_name: Papillomavirus Bivalent (Human) (Recombinant)

object_name: Persistent Infection


subject: UMLS:C4733962

object_name: cervical intraepithelial neoplasia


subject: UMLS:C4733962

object_name: dysplasia of cervix


subject: UMLS:C4733962

object_name: Vaginal intraepithelial neoplasia


subject: UMLS:C4733962

object_name: vulvar intraepithelial neoplasia


subject: UMLS:C4733962

object_name: cervical cancer


subject: UMLS:C4733962

object_name: cervical carcinoma


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: DRUGBANK:DB16539

subject_name: Escherichia coli


subject: DRUGBANK:DB16539


subject: DRUGBANK:DB16539


subject: DRUGBANK:DB16539


subject: DRUGBANK:DB16539


subject: DRUGBANK:DB16539


subject: DRUGBANK:DB16539


subject: PUBCHEM.COMPOUND:3367

object_name: Stage IV Renal Cell Cancer


subject: GTOPDB:4985


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: UMLS:C0699857

subject_name: Nitrate

object_name: Angina pectoris


subject: UMLS:C0699857

object_name: outcomes general quality of life


subject: UMLS:C0699857

object_name: Perceived quality of life


subject: UMLS:C0699857

object_name: Good quality of life


subject: UMLS:C0699857

object_name: myocardial ischemia


subject: UMLS:C0699857

object_name: coronary atherosclerosis


subject: CHEBI:17632


subject: CHEBI:17632


subject: CHEBI:17632


subject: CHEBI:17632


subject: CHEBI:17632


subject: CHEBI:17632


subject: CHEBI:48107

subject_name: Nitric acid


subject: CHEBI:48107


subject: CHEBI:48107


subject: CHEBI:48107


subject: CHEBI:48107


subject: CHEBI:48107


subject: CHEBI:31348

subject_name: Capecitabine

object_name: AIDS-Related Anal Carcinoma


subject: CHEBI:31348

object_name: Stage III Anal Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IIB Anal Cancer AJCC v8


subject: CHEBI:31348

object_name: anal margin carcinoma


subject: CHEBI:31348

object_name: anal squamous cell carcinoma


subject: CHEBI:31348

object_name: Anal Non-Keratinizing Squamous Cell Carcinoma


subject: CHEBI:31348

object_name: anal margin squamous cell carcinoma


subject: CHEBI:31348

object_name: squamous cell carcinoma of rectum


subject: CHEBI:31348

object_name: HIV infection


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:25357

subject_name: mitomycin


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357

object_name: Stage II Rectal Cancer AJCC v8


subject: CHEBI:25357

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Signs and Symptoms, Respiratory


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Parkinson disease


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:6413

subject_name: Letrozole

object_name: Subfertility


subject: CHEBI:64312

subject_name: Memantine

object_name: sickle cell disease


subject: CHEBI:2704

subject_name: Anastrozole

object_name: breast disorder


subject: CHEBI:85993

subject_name: Palbociclib


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: CHEBI:691037

subject_name: Desoximetasone

object_name: Psoriasis of scalp


subject: UMLS:C3827103

object_name: Childhood Solid Neoplasm


subject: UMLS:C3827103

object_name: Adult Solid Neoplasm


subject: UMLS:C3827103

object_name: Solid Neoplasm


subject: CHEBI:27470

subject_name: Folic acid

object_name: granulomatous mastitis


subject: CHEBI:27470

object_name: Idiopathic granulomatous mastitis


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:24433

subject_name: group

object_name: periodontitis, chronic, adult


subject: CHEBI:24433

object_name: chronic periodontitis


subject: UMLS:C2720164

object_name: Myelodysplasia


subject: UMLS:C2720164

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C2720164

object_name: childhood myelodysplastic syndrome


subject: UMLS:C2720164

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C2720164

object_name: acute lymphoblastic leukemia


subject: UMLS:C2720164

object_name: acute myeloid leukemia


subject: CHEBI:93776

subject_name: Pevonedistat


subject: CHEBI:93776


subject: CHEBI:93776


subject: CHEBI:93776


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: chronic kidney disease


subject: CHEBI:32016

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:32016

object_name: fibrosis


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: thrombotic microangiopathy


subject: UNII:A3ULP0F556

object_name: Disorder related to bone marrow transplantation


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:31355

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: Breast cancer stage III


subject: CHEBI:31355

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:31355

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:31355

object_name: invasive breast carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: Breast cancer stage II


subject: PUBCHEM.COMPOUND:2767

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: malignant neoplasm of breast stage IIb


subject: PUBCHEM.COMPOUND:2767

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: invasive breast carcinoma


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: sexual disorder


subject: CHEBI:38545

object_name: physiological sexual disorder


subject: CHEBI:5001

subject_name: Fenofibrate


subject: CHEBI:5001


subject: GTOPDB:12989

subject_name: toripalimab

object_name: mismatch repair cancer syndrome 1


subject: GTOPDB:12989

object_name: Turcot syndrome


subject: GTOPDB:12989

object_name: Mismatch Repair Deficiency


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: MESH:C505143

subject_name: Boostrix

object_name: pertussis


subject: CHEBI:16335

subject_name: Adenosine

object_name: Supraventricular Tachycardia by ECG Finding


subject: CHEBI:16335

object_name: Supraventricular tachycardia


subject: CHEBI:16335

object_name: Supraventricular Tachycardia, CTCAE


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:75984

subject_name: Flecainide


subject: CHEBI:75984


subject: CHEBI:75984


subject: CHEBI:2663

subject_name: Amiodarone


subject: CHEBI:2663


subject: CHEBI:2663


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin


subject: PUBCHEM.COMPOUND:3062


subject: PUBCHEM.COMPOUND:3062


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:4551


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Marinesco-Sjogren syndrome


subject: UNII:52CMI0WC3Y

object_name: Microsatellite Stable


subject: UNII:52CMI0WC3Y

object_name: Mismatch Repair Protein Proficient


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox


subject: PUBCHEM.COMPOUND:71301229


subject: PUBCHEM.COMPOUND:71301229


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Metastatic ocular melanoma


subject: UNII:M89N0Q7EQR

object_name: Metastatic Uveal Melanoma


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: PR:000001151

subject_name: Toll-like receptor 1


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: Androgen excess


subject: CHEBI:8768

subject_name: Rabeprazole

object_name: Nonulcer dyspepsia


subject: CHEBI:2637

subject_name: Amikacin

object_name: lung disorder


subject: CHEBI:2637

object_name: Mycobacterium xenopi infection


subject: CHEBI:44185

subject_name: Methotrexate

object_name: diabetic retinopathy


subject: CHEBI:44185

object_name: Vitreomacular traction


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:231602

subject_name: Refametinib

object_name: neoplasm


subject: UMLS:C2745498


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: ovarian cancer


subject: GTOPDB:13085

object_name: ovarian neoplasm


subject: GTOPDB:13085

object_name: ovarian disease


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UNII:1XBY50W1OX


subject: UNII:1XBY50W1OX


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UMLS:C4725109


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib


subject: UNII:TWF0ML1CK8


subject: UNII:TWF0ML1CK8


subject: CHEBI:74947

subject_name: Thalidomide

object_name: thalassemia


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: cervical cancer


subject: UNII:6XG22YQM2Z

object_name: cervical carcinoma


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: Chronic low back pain


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0358845

subject_name: Analgesics and non-steroidal anti-inflammatory drugs


subject: UMLS:C5666926

subject_name: Anti-CD47/Anti-PD-L1 Bispecific Antibody 6MW3211

object_name: Advanced lung cancer


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:31236

object_name: metabolic syndrome X


subject: CHEBI:233364

subject_name: Bryostatin

object_name: prostate carcinoma


subject: CHEBI:233364

object_name: prostate cancer


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:28918

subject_name: Epinephrine

object_name: clavicle fracture


subject: CHEBI:124939

subject_name: Rigosertib

object_name: anal margin carcinoma


subject: CHEBI:124939

object_name: anal squamous cell carcinoma


subject: CHEBI:124939

object_name: skin squamous cell carcinoma


subject: CHEBI:124939

object_name: squamous cell lung carcinoma


subject: CHEBI:124939

object_name: squamous cell carcinoma of penis


subject: CHEBI:124939

object_name: cervical squamous cell carcinoma


subject: CHEBI:124939

object_name: esophageal squamous cell carcinoma


subject: CHEBI:124939

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3896771

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:74947

object_name: canker sore


subject: CHEBI:74947

object_name: aphthous stomatitis


subject: CHEBI:37924

subject_name: Atazanavir

object_name: type 1 diabetes mellitus 1


subject: CHEBI:37924

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Anastomotic Leak


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Adult Central Nervous System Neoplasm


subject: CHEBI:72564

subject_name: Temozolomide


subject: UMLS:C5206703

subject_name: INCAGN 02390

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5206703

object_name: clear cell renal carcinoma


subject: UMLS:C5206703

object_name: renal cell adenocarcinoma


subject: UMLS:C5206703

object_name: refractory cytopenia of childhood


subject: UMLS:C5206703

object_name: renal cell carcinoma


subject: UMLS:C5206703

object_name: Microsatellite Instability


subject: UMLS:C5206703


subject: UMLS:C5206703

object_name: Gastroesophageal junction cancer


subject: UMLS:C5206703

object_name: triple-negative breast carcinoma


subject: UMLS:C5206703

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5206703

object_name: non-small cell lung carcinoma


subject: UMLS:C5206703

object_name: mismatch repair cancer syndrome 1


subject: UMLS:C5206703

object_name: Turcot syndrome


subject: UMLS:C5206703

object_name: Mismatch Repair Deficiency


subject: UMLS:C5206703

object_name: small cell lung carcinoma


subject: UMLS:C5206703

object_name: liver carcinoma


subject: UMLS:C5206703

object_name: trabecular adenocarcinoma


subject: UMLS:C5206703

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C5206703

object_name: carcinoma of esophagus


subject: UMLS:C5206703

object_name: esophageal cancer


subject: UMLS:C5206703

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5206703

object_name: neoplasm of esophagus


subject: UMLS:C5206703

object_name: cervical cancer


subject: UMLS:C5206703

object_name: cervical carcinoma


subject: UMLS:C5206703

object_name: Stomach cancer


subject: UMLS:C5206703

object_name: gastric cancer


subject: UMLS:C5206703

object_name: ovarian cancer


subject: UMLS:C5206703

object_name: ovarian neoplasm


subject: UMLS:C5206703

object_name: ovarian carcinoma


subject: UMLS:C5206703

object_name: uveal melanoma


subject: UMLS:C5206703

object_name: Mesothelioma


subject: UMLS:C5206703

object_name: mesothelial neoplasm


subject: UMLS:C5206703

object_name: malignant mesothelioma


subject: UMLS:C5206703

object_name: melanoma


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class

object_name: tardive dyskinesia


subject: CHEBI:27306

subject_name: vitamin B6


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Stage III Cutaneous Melanoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: Advanced Melanoma


subject: MESH:C000629782

object_name: Melanoma recurrent


subject: MESH:C000629782


subject: MESH:C000629782

object_name: Unresectable Melanoma


subject: MESH:C000629782

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: MESH:C000629782


subject: MESH:C000629782


subject: MESH:C000629782

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: CHEBI:94809

subject_name: Itopride

object_name: Fatty Liver


subject: CHEBI:94809


subject: UNII:7D0YB67S97

subject_name: Abatacept


subject: UMLS:C0378942


subject: CHEBI:9168

subject_name: Sirolimus

object_name: epilepsy


subject: CHEBI:9168

object_name: tuberous sclerosis 1


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Autoimmune reaction


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:R7O0O4110G

object_name: pancreatic neoplasm


subject: UNII:R7O0O4110G

object_name: exocrine pancreatic carcinoma


subject: UNII:R7O0O4110G

object_name: malignant pancreatic neoplasm


subject: UNII:R7O0O4110G

object_name: esophageal adenocarcinoma


subject: UNII:R7O0O4110G

object_name: lung adenocarcinoma


subject: UNII:R7O0O4110G

object_name: cervical adenocarcinoma


subject: UNII:R7O0O4110G

object_name: adenocarcinoma


subject: UNII:R7O0O4110G

object_name: bile duct adenocarcinoma


subject: UNII:R7O0O4110G

object_name: gastric adenocarcinoma


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: UMLS:C4039583

subject_name: Chimeric antigen receptor

object_name: diffuse large B-cell lymphoma


subject: UNII:19J3781LPM

subject_name: Itacitinib


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: rectal carcinoma


subject: UNII:28X28X9OKV

object_name: rectal cancer


subject: UNII:28X28X9OKV

object_name: Childhood Rectal Carcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C5908009

subject_name: Anti-DLK-1/MMAE Antibody-drug Conjugate TORL-4-500

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5908009

object_name: liver carcinoma


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid

object_name: type 2 diabetes mellitus


subject: CHEBI:37084

object_name: Insulin resistance


subject: CHEBI:37084

object_name: Problem of aging


subject: CHEBI:29998

subject_name: D-serine residue

object_name: schizophrenia


subject: CHEBI:29998

object_name: schizoaffective disorder


subject: CHEBI:17115

subject_name: Serine


subject: CHEBI:17115


subject: UMLS:C1880218

subject_name: serine, D-


subject: UMLS:C1880218


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Myocardial injury


subject: UNII:C8ADC441ME

object_name: myocardial ischemia


subject: UNII:C8ADC441ME

object_name: coronary atherosclerosis


subject: UNII:C5529G5JPQ

subject_name: ginger extract

object_name: colorectal adenoma


subject: CHEBI:47426

subject_name: Furosemide

object_name: acromegaly


subject: CHEBI:47426

object_name: Acral overgrowth


subject: UNII:H1396W7D1H

subject_name: FAVEZELIMAB

object_name: Hodgkin Disease


subject: UNII:H1396W7D1H

object_name: Adult Hodgkin Lymphoma


subject: UNII:H1396W7D1H

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C4684393

subject_name: Favezelimab


subject: UMLS:C4684393


subject: UMLS:C4684393


subject: CHEBI:15365

subject_name: Aspirin

object_name: Mammographic Breast Density


subject: PUBCHEM.COMPOUND:135565610

subject_name: hetrombopag

object_name: autoimmune thrombocytopenia


subject: PUBCHEM.COMPOUND:135565610

object_name: thrombocytopenia due to immune destruction


subject: UNII:9WGT51BDDL

subject_name: Hetrombopag


subject: UNII:9WGT51BDDL


subject: UMLS:C2699335

subject_name: cixutumumab

object_name: leiomyosarcoma


subject: UMLS:C2699335

object_name: Adult Leiomyosarcoma


subject: UMLS:C2699335

object_name: Adult Synovial Sarcoma


subject: UMLS:C2699335

object_name: synovial sarcoma


subject: UNII:2285XW22DR


subject: UNII:2285XW22DR


subject: UNII:2285XW22DR


subject: UNII:2285XW22DR


subject: CHEBI:28680

subject_name: Cytarabine

object_name: primary disorders


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Tako-tsubo cardiomyopathy


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:167309

subject_name: Methadone

object_name: Childhood Breast Carcinoma


subject: CHEBI:167309

object_name: breast carcinoma


subject: CHEBI:167309

object_name: breast cancer


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Effects of chemotherapy


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:29035

object_name: Pregnant


subject: CHEBI:29035

object_name: birth weight


subject: CHEBI:132082

subject_name: Entinostat

object_name: prostate adenocarcinoma


subject: UMLS:C4305866

object_name: myotonic dystrophy type 1


subject: UMLS:C1722268

subject_name: ACP 103

object_name: schizophrenia


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: castration-resistant prostate carcinoma


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: CHEBI:43689

subject_name: isopentylamine

object_name: Unresectable Hepatocellular Carcinoma


subject: CHEBI:42941


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: age


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: CHEBI:16755

subject_name: chenodiol

object_name: morbid obesity


subject: CHEBI:16755

object_name: Class 3 Obesity


subject: CHEBI:59594

subject_name: Colesevelam


subject: CHEBI:59594


subject: CHEBI:42797

subject_name: Gabapentin

object_name: spinal cord injury


subject: CHEBI:16199

subject_name: Urea

object_name: Hyponatremia


subject: CHEBI:16199

object_name: Hyponatremia, CTCAE


subject: CHEBI:16199

object_name: inappropriate ADH syndrome


subject: CHEBI:16199

object_name: subarachnoid hemorrhage


subject: UMLS:C2933627

object_name: rheumatoid arthritis


subject: PR:000011331

subject_name: neurogenic locus notch homolog protein 1

object_name: mercury poisoning


subject: CHEBI:38801

subject_name: isophthalamide


subject: UMLS:C5447779

subject_name: Axl/Mer/CSF1R Inhibitor Q702

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5447779

object_name: acute myeloid leukemia


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:4672

object_name: Stage IIA Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:4672

object_name: Stage IB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:4672

object_name: Stage IA Lung Non-Small Cell Carcinoma AJCC v7


subject: UMLS:C1328134

subject_name: matuzumab

object_name: ovarian cancer


subject: UMLS:C1328134

object_name: ovarian neoplasm


subject: UMLS:C1328134

object_name: ovarian carcinoma


subject: CHEBI:4903

subject_name: Ethinylestradiol

object_name: Osteopenia


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:71219

subject_name: Pazopanib

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:86821

object_name: Hypertension stage 1


subject: CHEBI:26125

subject_name: phytosterols


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: Pregnant


subject: UMLS:C4552074

object_name: Hepatic impairment


subject: CHEBI:91408

subject_name: Fedratinib


subject: UMLS:C4053657

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:87631

subject_name: statin

object_name: Hypercholesterolemia


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Parkinson disease


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: abdominal aortic aneurysm


subject: CHEBI:59527

object_name: Acute Pain


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: RXCUI:36572

subject_name: Sinemet


subject: CHEBI:233197

subject_name: devimistat

object_name: Advanced cancer


subject: CHEBI:233197

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:233197

object_name: Embolism, Tumor


subject: CHEBI:233197

object_name: Neoplasm Metastasis


subject: CHEBI:233197

object_name: Solid Neoplasm


subject: CHEBI:233197

object_name: adult lymphoma


subject: CHEBI:233197

object_name: lymphoma


subject: CHEBI:233197

object_name: pediatric lymphoma


subject: UMLS:C2703200

subject_name: CPI 613


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UNII:I1679X069H

subject_name: Brilacidin


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: Frontal balding


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Metastatic thymic carcinoma


subject: CHEBI:85994

object_name: thymoma type B3


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P